Role of concomitant chemoradiation in locally advanced head and neck cancers

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 10, 2014, Pages 4147-4152

  Lasrado, Savita ^a   Moras, Kuldeep ^a   Pinto, George Jawahar Oliver ^a   Bhat, Mahesh ^a   Hegde, Sanath ^b   Sathian, Brijesh ^c   Luis, Neil Aaron ^d  

^a FATHER MULLER MEDICAL COLLEGE   (India)

^b Indian Institute of Oncology   (India)

^c MANIPAL COLLEGE OF MEDICAL SCIENCES   (Nepal)

^d Private Practice   (Australia)

Author keywords

Carboplatin; Chemoradiation; Head and neck cancer; Radiotherapy; Squamous cell carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN;

ADULT; AGED; ANEMIA; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; DISEASE FREE SURVIVAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMAN; HYPOPHARYNGEAL NEOPLASMS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; NECK; OROPHARYNGEAL NEOPLASMS; PATHOLOGY; PROCEDURES; PROSPECTIVE STUDY; RADIATION DOSE; SALVAGE THERAPY; SURVIVAL RATE; THROMBOCYTOPENIA; TUMOR RECURRENCE; WOUND HEALING;

ADULT; AGED; ANEMIA; ANTINEOPLASTIC AGENTS; CARBOPLATIN; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; HYPOPHARYNGEAL NEOPLASMS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; MUCOSITIS; NECK; NEOPLASM RECURRENCE, LOCAL; OROPHARYNGEAL NEOPLASMS; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; SALVAGE THERAPY; SURVIVAL RATE; THROMBOCYTOPENIA; WOUND HEALING;

EID: 84903541520     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.10.4147     Document Type: Article

References (24)

1. Al-Sarraf M (1988). Head and neck cancer: chemotherapy concepts. Semin Oncol, 15, 70-85.
2. Baykara M, Buyukberber S, Ozturk B, et al (2013). Efficacy and safety of concomitant chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced squamous cell head and neck cancers. Asian Pac J Cancer Prev, 14, 2557-61.
3. Bertino G, Occhini A, Falco CE, et al (2009).Concurrent intraarterial carboplatin administration and radiation therapy for treatment of advanced head and neck squamous cell carcinoma: short term results. BMC Cancer, 9, 313.
4. Calais G, Alfonsi M, Bardet E, et al (1999). Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced stage oropharynx carcinoma. J Natl Cancer Inst, 91, 2081-6.
5. Calcattera TC, Juillard GJ (1995). Oral cavity and hypopharynxhead and neck cancer. In: Haskell CM, Berek JS, editors. Cancer Treatment. WB Saunders Co:Philadelphia. p.726-732.
6. Denis F, Garaud P, Bardet E, et al (2004). Final results of the 94-01 French head and neck oncology and radiotherapy group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced stage oropharynx carcinoma. J Clin Oncol, 22, 69-76.
7. Dinshaw KA, Rao DN, Ganesh B (2000). Hospital based cancer registry, annual report, Tata Memorial Hospital, Mumbai, India.
8. Eisenberger M, Sinibaldi V, Jacobs M, Gray W (1988). Simultaneous treatment with carboplatin (NSC-241-240) and radiotherapy in advanced unresectable squamous cell carcinomas of the head and neck. Cancer Treat Rev, 1988, 3-7.
9. Haddad R, O'Neill A, Rabinowits G, et al (2013). Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial. Lancet Oncol, 14, 257-64.
10. Herman LC, Chen L, Garnett A, et al (2014). Comparison of carboplatin-paclitaxel to docetaxel-cisplatin-5-flurouracil induction chemotherapy followed by concurrent chemoradiation for locally advanced head and neck cancer. Oral Oncol, 50, 52-8.
11. Hosokawa Y, Kamada T, Shirato H, et al (1995). Simultaneous carboplatin and radiotherapy for all stages of head and neck squamous cell carcinoma. Clin Oncol, 7, 168-72.
12. Mabanta SR, Mendenhall WM, Stringer SP, Cassisi NJ (1999). Salvage treatment for neck recurrence after irradiation alone for head and neck squamous cell carcinomawith clinically positive neck nodes. Head Neck, 21, 591-4.
13. Nam EJ, Lee M, Yim GA, et al (2013). Comparison of carboplatinand cisplatin-based concurrent chemoradiotherapy in locally advanced cervical cancer patients with morbidity risks. Oncologist, 18, 843-9.
14. Nguyen NP, Vos P, Smith HJ, et al (2007). Concurrent chemoradiation for locally advanced oropharyngeal cancer. Am J Otolaryngol, 28, 3-8.
15. Okami K, Hamano T, Takeo T, Sugimoto R, Sekine M (2007). A survey of head and neck malignancy at Tokai University Hospital. Tokai J Exp Clin Med, 32, 62-6.
16. Pignon JP, Bourhis J, Domenge C, Designe L (2000). Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta. analyses of updated individual data. Lancet, 355, 949-55.
17. Robert JK, Benjamin GW, Cleveland OH, et al (1988). Squamous cell carcinoma of head and neck in patients 40 years of age and younger. Laryngocsope, 531-3.
18. Seiwert TY, Salama JK, Vokes EE (2007). The concurrent chemoradiation paradigm-general principles. Nat Clin Pract Oncol, 4, 86-100.
19. Shah JP, Ladd W (1995). Treatment of cancer of the head and neck. CA Cancer J Clin, 45, 352-68.
20. Taguchi T, Tsukuda M, Mikami Y, et al (2009). Treatment results and prognostic factors for advanced squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy. Auris Nasus Larynx, 36, 199-204.
21. Takiar R, Nadayil D, Nandakumar A (2010). Projections of number of cancer cases in India (2010-2020) by cancer groups. Asian Pac J Cancer Prev, 11, 1045-9.
22. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK (1993). Head and neck cancer. N Engl J Med, 328, 184-94.
23. Yang LX, Douple E, Wang HJ (1995). Irradiation-enhanced binding of carboplatin to DNA. Int J Radiat Biol, 68, 609-614.
24. Zhu WG, Zhou K, Yu CH, et al (2012). Efficacy analysis of simplified intensity-modulated radiotherapy with high or conventional dose and concurrent chemotherapy for patients with neck and upper thoracic esophageal carcinoma. Asian Pac J Cancer Prev, 13, 803-7.